Literature DB >> 24461703

Positive nuclear expression of KLF8 might be correlated with shorter survival in gastric adenocarcinoma.

Li-Sung Hsu1, Pei-Ru Wu2, Ken-Tu Yeh3, Chung-Min Yeh2, Ko-Hung Shen2, Chih-Jun Chen4, Maw-Soan Soon5.   

Abstract

Krűppel-like factor 8 (KLF8) is important in cell proliferation, epithelial-to-mesenchymal transition, cell migration, and invasion. Gastric adenocarcinoma is among the leading causes of cancer-related death in the world. In this study, the clinicopathologic correlation of KLF8 expression with gastric adenocarcinoma in Taiwan was investigated. The nuclear localization of KLF8 was correlated with advanced stage (P = .008) and 3-year survival rate (P = .043). The nuclear expression of KLF8 was significantly higher in the diffused type of gastric adenocarcinoma compared with the intestinal type (P = .036). Kaplan-Meier analysis results showed that patients with positive nuclear KLF8 had significantly lower overall survival rate compared with those with negative nuclear KLF8 (P = .011). Univariate analysis results indicated that positive nuclear KLF8 expression, advanced stage, and lymph node metastasis are correlated with lower overall survival. Positive nuclear KLF8 might be correlated with lower survival in gastric adenocarcinoma patients and might be an oncogene property in gastric adenocarcinoma carcinogenesis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric adenocarcinoma; Krűppel-like factor 8; survival

Mesh:

Substances:

Year:  2013        PMID: 24461703     DOI: 10.1016/j.anndiagpath.2013.12.001

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  8 in total

Review 1.  SP and KLF Transcription Factors in Digestive Physiology and Diseases.

Authors:  Chang-Kyung Kim; Ping He; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Gastroenterology       Date:  2017-03-30       Impact factor: 22.682

2.  Krüppel-like factor 8 induces epithelial-to-mesenchymal transition and promotes invasion of pancreatic cancer cells through transcriptional activation of four and a half LIM-only protein 2.

Authors:  Xiaoping Yi; Hongyan Zai; Xueying Long; Xiaoyi Wang; Wenzheng Li; Yixiong Li
Journal:  Oncol Lett       Date:  2017-08-09       Impact factor: 2.967

3.  KLF10 Functions as an Independent Prognosis Factor for Gastric Cancer.

Authors:  Yueh-Min Lin; Kun-Tu Yeh; Chung-Min Yeh; Maw-Soan Soon; Li-Sung Hsu
Journal:  Medicina (Kaunas)       Date:  2022-05-26       Impact factor: 2.948

4.  Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.

Authors:  Bharath Kumar Velmurugan; Kun-Tu Yeh; Chien-Hung Lee; Shu-Hui Lin; Mei-Chung Chin; Shang-Lun Chiang; Zhi-Hong Wang; Chun-Hung Hua; Ming-Hsui Tsai; Jan-Gowth Chang; Ying-Chin Ko
Journal:  Oncotarget       Date:  2016-03-08

5.  Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis.

Authors:  Yifei Liu; Xiufang Yao; Qing Zhang; Li Qian; Jia Feng; Tingting Bian; Jianguo Zhang; Ye Tian
Journal:  Exp Ther Med       Date:  2017-06-20       Impact factor: 2.447

6.  ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients.

Authors:  Alicja E Grzegorzewska; Leszek Niepolski; Monika K Świderska; Adrianna Mostowska; Ireneusz Stolarek; Wojciech Warchoł; Marek Figlerowicz; Paweł P Jagodziński
Journal:  BMC Med Genet       Date:  2018-11-09       Impact factor: 2.103

7.  The level of Krüppel-like factor 8 expression predicts prognosis and metastasis in various carcinomas.

Authors:  Jun Liu; Huimin Zheng; Yangyang Ding; Manman Li; Jingrong Li; Jiaojiao Guo; Linhui Hu; Lianfang Pu; Shudao Xiong
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

8.  KLF8 is associated with poor prognosis and regulates glycolysis by targeting GLUT4 in gastric cancer.

Authors:  Anwei Mao; Xiang Zhou; Yanxia Liu; Junbin Ding; Aiyu Miao; Gaofeng Pan
Journal:  J Cell Mol Med       Date:  2019-05-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.